ABSTRACT
INTRODUCTION
Alzheimer's disease (AD) is one of the most common chronic neurodegenerative disorders, and is characterized clinically by progressive memory loss and pathologically by the formation of extracellular senile plaques and intracellular neurofibrillary tangles (NFTs). Senile plaques are formed by accumulated amyloid β (Aβ) and NFTs are attributed to hyperphosphorylated tau protein [1] .
Insulin-like growth factor 1 (IGF-1), the IGF-1 receptor, and IGF-1-binding proteins are widely expressed in the rodent and human brains [2] . Emerging evidence has revealed the essential roles of IGF-1 in the brain, including its contribution to metabolism, neuromodulation, neuroendocrine secretion, and cognitive functions [3] .
Besides, an age-related decline of IGF-1 [4] and an association between deranged IGF-1-mediated signaling and AD have been reported. Further, IGF-1 accelerates Aβ clearance from the brain and reduces tau phosphorylation by inhibiting glycogen synthase kinase 3 [5, 6] .
MicroRNAs (miRs) are non-coding RNAs of ~22 nucleotides and are widely distributed in eukaryotic cells.
miRs regulate gene expression via the repression of translation or the induction of mRNA degradation by basepairing with the 3'-untranslated regions (3'-UTRs) of their target mRNAs [7] . Many brain-enriched or brain-specific miRs have been identified and shown to play important roles in the regulation of energy metabolism, synaptic plasticity, and memory formation [8] . In silico studies of miR 746 expression profi les in AD patients or transgenic AD models have been reported by several groups, and many miRs are known to be involved in Aβ production and clearance as well as in tauopathy [9] . APP/PS1 double-transgenic mice overexpressing the amyloid precursor protein (APP) with the Swedish mutation and presenilin-1 with deletion of exon 9 exhibit early Aβ deposition accompanied by cognitive decline, corresponding to a form of early-onset AD. Several miRs, including miR-34a and miR-98, are up-regulated in APP/ PS1 mice compared to control mice [10] .
MiR-98 regulates Fas and Fas-mediated apoptosis, as well as the production of interleukin 6 (IL-6) and . MiR-98 dysfunction has been found in several carcinomas [12] . However, its role in AD is not clear. In this study, we explored the role of miR-98 in the processes of Aβ production and tau phosphorylation.
MATERIALS AND METHODS

Animals
APP/PS1 mice were purchased from the Jackson Laboratory (Bar Harbor, ME). They were kept at 22°C
under a 12 h:12 h light/dark cycle. All animal experiments were performed using protocols approved by the Animal Care and Use Committee of our institution. 
Cell Lines and Cell Culture
Plasmids
The miR-98 overexpression plasmid and the control vector were from GeneCopoeia (Rockville, MD). The IGF-1 shorthairpin RNA (shRNA) and control shRNA plasmids were from GenePharm (Shanghai, China).
RNA Extraction and Real-time Quantitative PCR (qPCR)
Total RNA was isolated from mouse hippocampus samples or cells using the TRIzol reagent (Invitrogen). RNA was reverse-transcribed into cDNA using reverse transcriptase (Tiangen, Beijing, China). MiRs were prepared using a microRNA extraction kit (Tiangen). The expression of miR-98 was normalized to that of U6 snRNA. The expression of IGF-1 was normalized to that of β-actin.
3'-UTR Luciferase Reporter Assays
The sequence encoding the precursor of miR-98 (premiR-98: MI0000586) was inserted into the pEZX-MR01
vector ( vector was used as a negative control. Renilla and firefly luciferase activity was assessed using the Dual-Luciferase
Reporter Assay System (Promega).
Western Blot Analysis
Total cells or tissue lysates were prepared and subjected to 15% SDS-PAGE, transferred onto polyvinylidene difl uoride membranes, and blotted as described previously [8] .
Enzyme-linked Immunosorbent (ELISA) Assay
Aβ42 levels in cell lysates were quantifi ed using sandwich ELISA, as described previously [8] and according to the instructions of the Aβ42 mouse ELISA kit from Abcam (Cambridge, United Kingdom).
Statistical Analysis
Data are presented as mean ± SD. Statistical signifi cance was determined using Student's t-test. Differences were considered statistically signifi cant at P <0.05.
RESULTS
IGF-1 Protein Is Significantly Down-regulated in 6-month-old APP/PS1 Mice
Consistent with a previous report [10] , miR-98 expression was increased in 6-month-old APP/PS1 mice (Fig. 1A) .
MiR-7d/e, members of the miR-7 family, were also detected using qPCR (Fig. 1A) . Since IGF-1 was predicted to be a target of miR-98 by bioinformatics, we also measured IGF-1 mRNA levels using qPCR, and found no signifi cant difference between APP/PS1 and control mice (Fig. 1B ).
However, the protein level of IGF-1 was signifi cantly lower in APP/PS1 mice than in control mice (Fig. 1C) , suggesting the post-transcriptional regulation of IGF-1 expression in APP/PS1 mice.
IGF-1 Is A Direct Target of miR-98
To further confirm the connection between IGF-1 and its regulators in APP/PS1 mice compared with control mice, we combined Pictar, miRbase, and Targetscan to screen for potential microRNA-binding sequences. One binding site of miR-98 was found within the 3'-UTR of IGF-1 ( (Fig. 2B) . These results suggested that miR-98 inhibits IGF-1 expression posttranscriptionally.
MiR-98 Inhibits IGF-1 Translation
To directly validate whether miR-98 reduces the level of endogenous IGF-1, we transfected miR-98 into N2a/ WT cells and found that the IGF-1 protein level was signifi cantly down-regulated compared with that in N2a/WT cells transfected with control vector (Fig. 3A) . In contrast, treatment with the inhibitor of miR-98 for 48 h led to a significant increase in the level of the endogenous IGF-1 protein (Fig. 3B) . However, the levels of IGF-1 mRNA did not vary signifi cantly among these experiments, suggesting that a post-transcriptional mechanism is involved in the inhibition of IGF-1 translation.
MiR-98 Increases Aβ Production and Tau Phosphorylation by Targeting IGF-1
To investigate the role of miR-98 in AD, we next used ELISA to measure the level of Aβ42 in lysates of N2a/ APP cells that stably expressed human APP. The level of Aβ42 in N2a/APP cell lysates was increased significantly after transfection with miR-98, whereas 50 ng/mL IGF-1 (Fig. 4A) .
Conversely, inhibition of miR-98 reduced the level of Aβ42 in the lysates of N2a/APP compared with control transfected N2a/APP cells (Fig. 4B) . Similarly, miR-98 vector transfection in N2a/WT cells increased tau phosphorylation at several sites, while 50 ng/mL IGF-1 application reversed these increases (Fig. 5A, B) . Besides, inhibition of miR-98 reduced the tau phosphorylation ( 
DISCUSSION
AD is the most common type of dementia in the elderly. It is characterized by impaired higher brain functions, including memory, thinking, and personality. AD is pathologically characterized by synaptic impairment, accumulation of NFTs, and Aβ deposition [13] . IGF-1 is decreased in AD patients and transgenic models of AD, and its therapeutic value has been described in several animal models [14, 15] .
Emerging evidence indicates that IGF-1 has a direct effect on Aβ metabolism and clearance [16] . Carro et al. demonstrated that the administration of IGF-1 to aged rats by chronic subcutaneous infusion reduces the level of Aβ in the brain parenchyma and increases the level of Aβ in the cerebrospinal fl uid [17] . IGF-1 accelerates Aβ clearance from the cerebral parenchyma. Similarly, IGF-1 decreases the level of endogenous Aβ in Tg2576 transgenic mice, a model of AD amyloidosis. Treatment with IGF-1 remarkably reduces the immunoreactivity of Aβ in 1-year-old Tg2576 mice [18] . In another animal model of AD (APP/PS2 mice) in which impaired hippocampal-dependent cognition is accompanied by the early formation of Aβ plaques, systemic IGF-I administration for 3 months improves spatial learning and memory and decreases the total brain Aβ load [17] .
IGF-1 also infl uences the development of NFTs [19] . In AD, the hyperphosphorylation of tau impairs its function of promoting microtubule stabilization and assembly.
Hyperphosphorylated tau dissociates from microtubules, forms abnormal filaments, and aggregates as NFTs.
IGF-1 reduces the phosphorylation of tau at multiple sites. In addition, IGF-1 promotes the binding of tau to microtubules in cultured human neuronal cells [5] . In insulin receptor substrate 2-knockout mice, disruption of the IGF-1 signaling pathway increases tau phosphorylation in the brain [20] . Taken energy metabolism, neurogenesis, and major signaling pathways [21, 22] . Compelling evidence indicates the presence of a direct link between miRs and AD [23, 24] . Studies of miR expression profi les have identifi ed numerous miRs that are involved in AD. Many of these miRs regulate Aβ formation by targeting enzymes involved in the Aβ production process or other molecules indirectly [8, 25] . IGF-1 is negatively regulated by some miRs, including miR-1, miR-206, and miR-320, in many physiological processes [26, 27] .
MiR-98 is involved in the regulation of Fas and Fasmediated apoptosis [28] . In addition, it inhibits the TP53 pathway and regulates cisplatin-induced cell death [29] . MiR-98 also plays essential roles in the immune system by targeting several interleukins [11] . However, its role in the central nervous system is not clear. Here, we demonstrated that miR-98 inhibited IGF-1 translation in vitro and increased Aβ formation and tau phosphorylation by downregulating IGF-1. As miR-98 is widely involved in the regulation of synaptic plasticity, IL-6 and IL-10 production, and apoptosis, other molecules participating in the regulation of Aβ formation and tau phosphorylation might be regulated by miR-98,.
In conclusion, we showed that miR-98 negatively 
